OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
364558

Medical Net Inc

Healthcare Facilities & ServicesVerified

Medical Net Inc has a liquidity position characterized by a current ratio of 1.53, indicating the company can cover its short-term liabilities with its short-term assets. The company holds JPY 1,456,383,000 in cash and equivalents, which is a significant portion of its total assets of JPY 4,080,462,000. However, the company reported negative operating cash flow of JPY -80,856,000 and free cash flow of JPY -119,412,000, suggesting cash outflows from operations. Profitability metrics show a return on equity of -3.97% and a return on assets of -1.67%, indicating the company is not generating returns for its shareholders or assets. The company's operating income was JPY -363,563,000 and net income was JPY -68,148,000, reflecting a loss-making position. The debt-to-equity ratio of 0.73 suggests the company is moderately leveraged. The company's revenue is distributed across three segments: Media Platform, Medical Institution Management Support, and Medical BtoB. The Media Platform segment provides health and beauty information, while the Medical Institution Management Support segment offers SEM and dental clinic services. The Medical BtoB segment operates a portal for dental workers. The company's geographic exposure is primarily in Japan, with no disclosed international operations. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The company's recent financial performance shows a decline in profitability, with a net loss of JPY 68,148,000. The company's liquidity risk is low, and there are no immediate filing-based dilution flags. The company's capital expenditure of JPY -131,540,000 indicates investment in long-term assets. Recent events include the company's latest actual EPS of -7.64 JPY and revenue of 6,077,800,000 JPY. The company's financial performance and strategic direction will be closely monitored for any changes in its operational and financial health.

30-day price · 3645(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyMedical Net Inc
Ticker3645.T
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Medical Net Inc operates in the healthcare sector, primarily through media platform, medical institution management support, and medical BtoB services, generating revenue from advertising, dental clinic operations, and B2B portal services.

Classification. Medical Net Inc is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Healthcare Facilities & Services industry with a confidence level of 0.92.

Medical Net Inc has a liquidity position characterized by a current ratio of 1.53, indicating the company can cover its short-term liabilities with its short-term assets. The company holds JPY 1,456,383,000 in cash and equivalents, which is a significant portion of its total assets of JPY 4,080,462,000. However, the company reported negative operating cash flow of JPY -80,856,000 and free cash flow of JPY -119,412,000, suggesting cash outflows from operations. Profitability metrics show a return on equity of -3.97% and a return on assets of -1.67%, indicating the company is not generating returns for its shareholders or assets. The company's operating income was JPY -363,563,000 and net income was JPY -68,148,000, reflecting a loss-making position. The debt-to-equity ratio of 0.73 suggests the company is moderately leveraged. The company's revenue is distributed across three segments: Media Platform, Medical Institution Management Support, and Medical BtoB. The Media Platform segment provides health and beauty information, while the Medical Institution Management Support segment offers SEM and dental clinic services. The Medical BtoB segment operates a portal for dental workers. The company's geographic exposure is primarily in Japan, with no disclosed international operations. The company's growth trajectory is uncertain, with no specific revenue growth projections provided. The company's recent financial performance shows a decline in profitability, with a net loss of JPY 68,148,000. The company's liquidity risk is low, and there are no immediate filing-based dilution flags. The company's capital expenditure of JPY -131,540,000 indicates investment in long-term assets. Recent events include the company's latest actual EPS of -7.64 JPY and revenue of 6,077,800,000 JPY. The company's financial performance and strategic direction will be closely monitored for any changes in its operational and financial health.
Key takeaways
  • Medical Net Inc is currently operating at a loss, with a net income of JPY -68,148,000 and a return on equity of -3.97%.
  • The company's liquidity position is stable, with a current ratio of 1.53 and JPY 1,456,383,000 in cash and equivalents.
  • The company's revenue is generated from three segments, with a focus on media platform, medical institution management support, and medical BtoB services.
  • # RATIONALES
  • {
  • "margin_outlook_rationale": "The company's margin outlook is negative due to its current net loss and negative return on equity.",
  • "rd_outlook_rationale": "No specific R&D outlook is provided, but the company's focus on media and BtoB services suggests ongoing investment in technology and platform development.",
Financial snapshot
PeriodHA-latest
CurrencyJPY
Revenue$6.08B
Gross profit$1.97B
Operating income-$363.6M
Net income-$68.1M
R&D
SG&A
D&A
SBC
Operating cash flow-$80.9M
CapEx-$131.5M
Free cash flow-$119.4M
Total assets$4.08B
Total liabilities$2.36B
Total equity$1.72B
Cash & equivalents$1.46B
Long-term debt$1.26B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$6.08B-$363.6M-$68.1M-$119.4M
FY-1$5.25B$123.2M$6.0M$24.9M
FY-2$4.50B$195.8M$116.2M$115.1M
FY-3$3.75B$529.3M$380.1M$389.8M
FY-4$2.90B$252.7M$129.7M$143.4M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$4.08B$1.72B$1.46B
FY-1$3.99B$1.91B$1.53B
FY-2$3.47B$1.92B$1.52B
FY-3$3.15B$1.70B$1.13B
FY-4$2.11B$1.24B$868.7M
PeriodOCFCapExFCFSBC
FY0-$80.9M-$131.5M-$119.4M
FY-1$119.6M-$32.8M$24.9M
FY-2$429.1M-$20.6M$115.1M
FY-3$342.5M-$2.2M$389.8M
FY-4$391.9M-$13.0M$143.4M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.62B$27.1M$34.6M
FQ-1$1.77B$69.7M$68.9M
FQ-2$1.56B$22.7M$21.6M
FQ-3$1.66B-$283.0M$77.1M
FQ-4$1.51B-$119.7M-$128.2M
FQ-5$1.55B$47.1M$18.5M
FQ-6$1.36B-$8.0M-$35.5M
FQ-7$1.60B-$13.0M-$40.5M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$4.52B$1.99B$1.98B
FQ-1$4.56B$1.95B$1.94B
FQ-2$4.25B$1.87B$1.54B
FQ-3$4.08B$1.72B$1.46B
FQ-4$4.13B$1.66B$1.40B
FQ-5$4.35B$1.85B$1.44B
FQ-6$3.89B$1.84B$1.37B
FQ-7$3.99B$1.91B$1.53B
PeriodOCFCapExFCFSBC
FQ0
FQ-1$247.6M-$6.4M
FQ-2
FQ-3-$80.9M-$131.5M
FQ-4
FQ-5-$55.7M-$18.9M
FQ-6
FQ-7$119.6M-$32.8M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.72B
Net cash$198.9M
Current ratio1.5
Debt/Equity0.7
ROA-1.7%
ROE-4.0%
Cash conversion1.2%
CapEx/Revenue-2.2%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
Metric3645Activity
Op margin-6.0%11.5% medp25 9.9% · p75 15.0%bottom quartile
Net margin-1.1%8.6% medp25 6.3% · p75 12.4%bottom quartile
Gross margin32.3%28.8% medp25 28.8% · p75 28.8%top quartile
CapEx / revenue-2.2%4.2% medp25 3.8% · p75 4.2%bottom quartile
Debt / equity73.0%71.3% medp25 60.7% · p75 71.3%top quartile
Observations
IR observations
Last actual EPS-7.64 JPY
Last actual revenue6,077,800,000 JPY
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-04 05:09 UTC#316cb934
Market quoteclose JPY 305.00 · shares 0.01B diluted
no public URL
2026-05-04 02:08 UTC#ee2aa475
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 05:11 UTCJob: e7e55f6b